NI
72
4
FRT
46
-2
TSCO
60
2
GME
67
2
HP
32
3
NRG
60
5
ROST
52
2
MNST
54
-5
IRM
41
3
UA
48
4
VTR
58
3
DUK
62
-2
XRX
27
2
OMC
50
-5
URI
42
2
AAL
18
-2
JCI
55
11
BIIB
38
-2
EXPE
67
-2
MRK
28
-5
NI
72
4
FRT
46
-2
TSCO
60
2
GME
67
2
HP
32
3
NRG
60
5
ROST
52
2
MNST
54
-5
IRM
41
3
UA
48
4
VTR
58
3
DUK
62
-2
XRX
27
2
OMC
50
-5
URI
42
2
AAL
18
-2
JCI
55
11
BIIB
38
-2
EXPE
67
-2
MRK
28
-5
Financhill
Back

Massimo Group 10K Form

Sell
16

MAMO
Massimo Group

Last Price:
$2.73
Seasonality Move:
0%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MAMO News And Ratings

See the #1 stock for the next 7 days that we like better than MAMO

MAMO Financial Statistics

Sales & Book Value

Annual Sales: $111.2M
Cash Flow: $9.1M
Price / Cash Flow: 17.98
Annual Sales: $0.56
Price / Book: 4.91

Profitability

EPS (TTM): 0.07700
Net Income (TTM): $3.2M
Gross Margin: $34.3M
Return on Equity: 15.31%
Return on Assets: 6.24%

Massimo Group Earnings Forecast

Key Massimo Group Financial Ratios

  • The Gross Profit Margin over the past 4 years for MAMO is 30.88%.
  • The Selling, General & Administrative Expenses for MAMO have been equal to 23.75% of Gross Profit Margin.
  • The Research & Development expenses have been 0.31% of Revenue.
  • The Interest Expense is 3.13% of Operating Income.
  • The Net Earning history of MAMO is 2.84% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 2 years.

Massimo Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Automobiles
Sector: Consumer Discretionary
Current Symbol: MAMO
Website: massimomotor.com

Debt

Debt-to-Equity Ratio: 0.24
Current Ratio: 1.74
Quick Ratio: 0.65

Price-to-Earnings

Trailing P/E Ratio: 34.13
Forward P/E Ratio: 0

MAMO Technical Analysis vs Fundamental Analysis

Sell
16
Massimo Group (MAMO) is a Sell

Is Massimo Group a Buy or a Sell?

  • Massimo Group stock is rated a Sell
    The current Massimo Group [MAMO] share price is $2.73. The Score for MAMO is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.